• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测局部晚期直肠癌新辅助放化疗病理完全缓解的列线图:对器官保留策略的影响

A nomogram predicting pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: implications for organ preservation strategies.

作者信息

Sun Yanwu, Chi Pan, Lin Huiming, Lu Xingrong, Huang Ying, Xu Zongbin, Huang Shenghui, Wang Xiaojie

机构信息

Department of Colorectal Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, PR China.

出版信息

Oncotarget. 2017 Jun 28;8(40):67732-67743. doi: 10.18632/oncotarget.18821. eCollection 2017 Sep 15.

DOI:10.18632/oncotarget.18821
PMID:28978067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5620207/
Abstract

PURPOSE

To determine predictors of pathological complete response (pCR) in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy (nCRT), and develop a predictive nomogram.

METHODS

A total of 522 locally advanced rectal cancer patients undergoing nCRT and curative resection between 2008 and 2014 were included. Uni- and multivariate analysis was performed to identify predictors of pCR. A nomogram was developed and validated by internal (n=425) and external validation (n=97).

RESULTS

With a median follow-up of 55 months, pCR was associated with better 5-year overall and disease-free survival, distant control, but similar local control. Logistic regression showed that post-CRT distance from the anal verge (OR =0.840, P = 0.022), post-CRT tumor size (OR = 0.565, P = 0.003), post-CRT circumferential extent of tumor (OR = 0.021, P < 0.001), pre-CRT CEA level (OR = 2.004, P = 0.033), and post-CRT CEA level (OR = 3.767, P = 0.038) were independently associated with pCR. A nomogram was developed with a C-index of 0.81 and 0.75 on internal and external validation, respectively.

CONCLUSION

pCR was associated with better long-term outcome. A nomogram was successfully developed to predict pCR. It could support decision-making in organ preservation strategies.

摘要

目的

确定接受新辅助放化疗(nCRT)的局部晚期直肠癌患者病理完全缓解(pCR)的预测因素,并开发一种预测列线图。

方法

纳入2008年至2014年间共522例接受nCRT及根治性切除的局部晚期直肠癌患者。进行单因素和多因素分析以确定pCR的预测因素。通过内部验证(n = 425)和外部验证(n = 97)开发并验证列线图。

结果

中位随访55个月,pCR与更好的5年总生存率、无病生存率、远处控制相关,但局部控制相似。逻辑回归显示,放化疗后距肛缘距离(OR = 0.840,P = 0.022)、放化疗后肿瘤大小(OR = 0.565,P = 0.003)、放化疗后肿瘤环周范围(OR = 0.021,P < 0.001)、放化疗前癌胚抗原(CEA)水平(OR = 2.004,P = 0.033)及放化疗后CEA水平(OR = 3.767,P = 0.038)与pCR独立相关。开发的列线图在内部验证和外部验证中的C指数分别为为0.81和0.75。

结论

pCR与更好的长期预后相关。成功开发了一种预测pCR的列线图。它可以为器官保留策略的决策提供支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8586/5620207/f058480ddf7b/oncotarget-08-67732-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8586/5620207/52b8753c118d/oncotarget-08-67732-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8586/5620207/53d9138f0584/oncotarget-08-67732-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8586/5620207/2cf23d929f10/oncotarget-08-67732-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8586/5620207/f058480ddf7b/oncotarget-08-67732-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8586/5620207/52b8753c118d/oncotarget-08-67732-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8586/5620207/53d9138f0584/oncotarget-08-67732-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8586/5620207/2cf23d929f10/oncotarget-08-67732-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8586/5620207/f058480ddf7b/oncotarget-08-67732-g004.jpg

相似文献

1
A nomogram predicting pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: implications for organ preservation strategies.预测局部晚期直肠癌新辅助放化疗病理完全缓解的列线图:对器官保留策略的影响
Oncotarget. 2017 Jun 28;8(40):67732-67743. doi: 10.18632/oncotarget.18821. eCollection 2017 Sep 15.
2
A nomogram to predict distant metastasis after neoadjuvant chemoradiotherapy and radical surgery in patients with locally advanced rectal cancer.预测局部晚期直肠癌患者新辅助放化疗及根治性手术后远处转移的列线图。
J Surg Oncol. 2017 Mar;115(4):462-469. doi: 10.1002/jso.24522. Epub 2017 Jan 20.
3
A dynamic nomogram for predicting pathologic complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.用于预测局部晚期直肠癌新辅助化疗病理完全缓解的动态列线图。
Cancer Med. 2024 Jun;13(11):e7251. doi: 10.1002/cam4.7251.
4
[Predictive factors associated with pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer].[直肠癌新辅助放化疗后病理完全缓解的相关预测因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Jun;17(6):556-60.
5
A Nomogram for Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy Using Semiquantitative Parameters Derived From Sequential PET/CT in Locally Advanced Rectal Cancer.一种利用局部晚期直肠癌序贯PET/CT衍生的半定量参数预测新辅助放化疗病理完全缓解的列线图。
Front Oncol. 2021 Oct 5;11:742728. doi: 10.3389/fonc.2021.742728. eCollection 2021.
6
Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.使用 18FDG-PET/CT 预测局部晚期直肠癌新辅助放化疗的病理反应。
Ann Surg Oncol. 2012 Jul;19(7):2178-85. doi: 10.1245/s10434-012-2248-z. Epub 2012 Mar 7.
7
Construction and Evaluation of Nomogram for Hematological Indicators to Predict Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.构建并评估血液学指标列线图预测局部进展期直肠癌新辅助放化疗后病理缓解的价值。
J Gastrointest Cancer. 2023 Sep;54(3):791-801. doi: 10.1007/s12029-022-00861-9. Epub 2022 Sep 14.
8
A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy.单机构对局部晚期直肠腺癌新辅助放化疗后病理完全缓解患者的长期随访
Int J Colorectal Dis. 2017 Mar;32(3):341-348. doi: 10.1007/s00384-016-2712-5. Epub 2016 Nov 24.
9
Adding Consolidation Capecitabine to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Propensity-Matched Comparative Study.在局部晚期直肠癌新辅助放化疗中加入卡培他滨巩固治疗:一项倾向评分匹配的比较研究。
Front Surg. 2022 Jan 27;8:770767. doi: 10.3389/fsurg.2021.770767. eCollection 2021.
10
A nomogram for predicting good response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a retrospective, double-center, cohort study.局部进展期直肠癌新辅助放化疗后疗效良好的预测列线图:一项回顾性、双中心、队列研究。
Int J Colorectal Dis. 2022 Oct;37(10):2157-2166. doi: 10.1007/s00384-022-04247-y. Epub 2022 Sep 1.

引用本文的文献

1
A dynamic nomogram for predicting pathologic complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.用于预测局部晚期直肠癌新辅助化疗病理完全缓解的动态列线图。
Cancer Med. 2024 Jun;13(11):e7251. doi: 10.1002/cam4.7251.
2
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.局部晚期直肠癌新辅助放化疗后残留扁平黏膜病变患者病理完全缓解的预测因素
Chin J Cancer Res. 2022 Aug 30;34(4):383-394. doi: 10.21147/j.issn.1000-9604.2022.04.06.
3
A nomogram for predicting good response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a retrospective, double-center, cohort study.

本文引用的文献

1
Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study.基于治疗前参数预测单纯新辅助化疗的局部晚期直肠癌早期反应的列线图:FOWARC研究的亚组疗效分析
Oncotarget. 2016 Jan 26;7(4):5053-62. doi: 10.18632/oncotarget.6469.
2
Watch and Wait?--Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer.观察等待?——术前癌胚抗原升高与直肠癌病理完全缓解率降低相关。
J Gastrointest Surg. 2016 Jan;20(1):43-52; discussion 52. doi: 10.1007/s11605-015-2987-9. Epub 2015 Nov 6.
3
局部进展期直肠癌新辅助放化疗后疗效良好的预测列线图:一项回顾性、双中心、队列研究。
Int J Colorectal Dis. 2022 Oct;37(10):2157-2166. doi: 10.1007/s00384-022-04247-y. Epub 2022 Sep 1.
4
The measurement and modification of hypoxia in colorectal cancer: overlooked but not forgotten.结直肠癌中缺氧的测量与调节:虽被忽视但未被遗忘。
Gastroenterol Rep (Oxf). 2022 Aug 25;10:goac042. doi: 10.1093/gastro/goac042. eCollection 2022.
5
Pre-Treatment Computed Tomography Radiomics for Predicting the Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Retrospective Study.治疗前计算机断层扫描影像组学预测局部晚期直肠癌新辅助放化疗疗效的回顾性研究
Front Oncol. 2022 May 10;12:850774. doi: 10.3389/fonc.2022.850774. eCollection 2022.
6
A multicentre cohort study assessing the utility of routine blood tests as adjuncts to identify complete responders in rectal cancer following neoadjuvant chemoradiotherapy.一项多中心队列研究评估了常规血液检查作为辅助手段在新辅助放化疗后识别直肠癌完全缓解患者的效用。
Int J Colorectal Dis. 2022 Apr;37(4):957-965. doi: 10.1007/s00384-022-04103-z. Epub 2022 Mar 24.
7
A Nomogram for Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy Using Semiquantitative Parameters Derived From Sequential PET/CT in Locally Advanced Rectal Cancer.一种利用局部晚期直肠癌序贯PET/CT衍生的半定量参数预测新辅助放化疗病理完全缓解的列线图。
Front Oncol. 2021 Oct 5;11:742728. doi: 10.3389/fonc.2021.742728. eCollection 2021.
8
Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy.血清载脂蛋白A-I可预测直肠癌对新辅助放化疗的反应。
Cancer Manag Res. 2021 Mar 18;13:2623-2631. doi: 10.2147/CMAR.S302677. eCollection 2021.
9
Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation.局部晚期直肠癌新辅助放化疗后 PET/CT 再分期的影响。
J Surg Res. 2019 Nov;243:242-248. doi: 10.1016/j.jss.2019.04.080. Epub 2019 Jun 21.
10
Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer.观察等待作为直肠癌的一种治疗策略。
Curr Colorectal Cancer Rep. 2018;14(2):37-55. doi: 10.1007/s11888-018-0398-5. Epub 2018 Mar 7.
Normalization of CEA Levels Post-Neoadjuvant Therapy is a Strong Predictor of Pathologic Complete Response in Rectal Cancer.
新辅助治疗后癌胚抗原(CEA)水平正常化是直肠癌病理完全缓解的有力预测指标。
J Gastrointest Surg. 2015 Jun;19(6):1106-12. doi: 10.1007/s11605-015-2814-3. Epub 2015 Apr 10.
4
Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer.局部进展期直肠癌患者放化疗后预测 ypN 状态的列线图。
Br J Cancer. 2014 Jul 15;111(2):249-54. doi: 10.1038/bjc.2014.256. Epub 2014 Jun 26.
5
Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.临床肿瘤大小和淋巴结状态可预测直肠癌新辅助放化疗后的病理完全缓解情况。
Int J Colorectal Dis. 2014 Mar;29(3):301-7. doi: 10.1007/s00384-013-1821-7. Epub 2014 Jan 14.
6
Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer.局部晚期直肠癌治疗中病理完全缓解的突变及临床预测因素
J Gastrointest Cancer. 2014 Mar;45(1):34-9. doi: 10.1007/s12029-013-9546-y.
7
Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer.直肠癌新辅助放化疗与手术的最佳时间间隔。
Br J Surg. 2013 Jun;100(7):933-9. doi: 10.1002/bjs.9112. Epub 2013 Mar 27.
8
Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.原发性切除的腹膜后软组织肉瘤的预后预测:基于大型肉瘤中心数据集的组织学特异性总生存和无病生存列线图。
J Clin Oncol. 2013 May 1;31(13):1649-55. doi: 10.1200/JCO.2012.44.3747. Epub 2013 Mar 25.
9
Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy.肝内胆管癌根治性切除术后的预后列线图。
J Clin Oncol. 2013 Mar 20;31(9):1188-95. doi: 10.1200/JCO.2012.41.5984. Epub 2013 Jan 28.
10
Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy.新辅助治疗后 T2 期直肠癌腔内局部切除术与腹腔镜全直肠系膜切除术的随机临床试验。
Br J Surg. 2012 Sep;99(9):1211-8. doi: 10.1002/bjs.8821.